The invention provides a health-care Chinese hawthorn leaf tea capable of reducing glucose and lipid. The health-care Chinese hawthorn leaf tea capable of reducing glucose and lipid comprises the following raw materials in parts by weight: 10-50 parts of Chinese hawthorn leaves, 10-20 parts of cortex magnoliae officinalis, 10-20 parts of albizia julibrissin, 10-20 parts of Chinese mosla herb, 10-20 parts of polygonatum kingianum, 10-20 parts of dried radix rehmanniae, 10-20 parts of cortex albiziae, 10-20 parts of lalang grass rhizome, 10-20 parts of poria cocos, 10-20 parts of salviae miltiorrhizae, 10-20 parts of mulberries, 10-20 parts of fortune eupatorium herb, 10-20 parts of gynostemma pentaphyllum, 10-20 parts of cortex mori radicis, 10-20 parts of cortex moutan, 10-20 parts of astragalus, 10-20 parts of coix seeds, and 10-20 parts of inula japonica. The Chinese hawthorn leaf flavonoid contained in the Chinese hawthorn leaves has a wide pharmacologic action, is especially beneficial to a cardiovascular system, has the pharmacologic actions of reducing blood pressure, reducing peripheral vascular resistance, expanding coronary artery, increasing coronary flow, reducing myocardial oxygen consumption, strengthening the heart, increasing cardiac output, resisting myocardial ischemia and platelet aggregation, improving blood rheology, removing oxygen radical, enhancing hypoxia tolerance, inducing dieresis and the like.